在呼吸道传染病中Acinetobacter baumannii的毒性因素和致病机制
Yake Yao1, Qi Chen1, Hua Zhou1
1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Antibiotics (Basel, Switzerland)
|December 23, 2023
概括
菌 (Acinetobacter baumannii) 是一种危险的病原体,会引起严重的呼吸道感染. 本综述详细介绍了其抗生素耐药性和毒性,有助于开发针对Acinetobacter baumannii感染的新疗法.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 肺部医学 肺部医学
背景情况:
- 宝曼尼菌 (Acinetobacter baumannii) 是导致医院和社区感染的重要原因,特别是呼吸器相关的肺炎.
- 这种机会性病原体表现出高的基因组可塑性,并拥有许多致病因子,有助于其致病性.
- 尽管对其与肺上皮的相互作用进行了广泛的研究,但对其整体致病过程的全面理解仍然不完整.
研究的目的:
- 审查当前关于抗生素耐药性和Acinetobacter baumannii的毒性因素的知识.
- 特别关注Acinetobacter baumannii在呼吸道感染中使用的致病机制.
- 为开发针对免疫病理或细胞内信号通路的新型治疗策略提供基础.
主要方法:
- 对Acinetobacter baumannii现有研究的文献综述.
- 综合有关抗生素耐药机制的信息.
- 关于呼吸道感染中的毒性因子和病原性策略的数据汇编.
主要成果:
- 巴曼尼菌 (Acinetobacter baumannii) 显示出显著的抗生素耐药性.
- 关键的毒性因素和基因组可塑性有助于其作为病原体的成功.
- 详细介绍了呼吸道感染中的特定致病机制,强调了其有害影响.
结论:
- 了解Acinetobacter baumannii的发病性对于对抗呼吸道感染至关重要.
- 为了开发有效的治疗方法,需要对免疫病理学和细胞内信号通路进行进一步的研究.
- 针对这些途径为消除Acinetobacter baumannii感染提供了一个有希望的途径.
更多相关视频
07:41Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization
Published on: August 4, 2023
3.4K
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.1K
相关概念视频
01:31Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
01:30Pneumonia I: Introduction
240
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
240
01:29Pneumonia II: Pathophysiology
279
The pathophysiology of pneumonia involves the following steps:
279
01:20Infection
8.0K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.0K
01:29Acute Respiratory Failure-V
142
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
142
01:30Acute Respiratory Failure-III
187
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
187